Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion

[1] Argyelan M(2005)Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study J Affect Disord 89 115-123

[2] Szabo Z(2000)Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain Eur Neuropsychopharmacol 10 177-188

[3] Kanyo B(1994)Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs Br J Pharmacol 113 485-495

[4] Tanacs A(1988)Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain Naunyn Schmiedebergs Arch Pharmacol 337 246-254

[5] Kovacs Z(1989)Frequency-dependence of serotonin autoreceptor but not alpha 2-adrenoceptor inhibition of [3H]-serotonin release in rat hypothalamic slices Naunyn Schmiedebergs Arch Pharmacol 339 60-64

[6] Janka Z(1986)In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals J Neurosci 6 2796-2801

[7] Pavics L(1991)Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat Neuropsychopharmacology 5 219-229

[8] Besson A(1994)Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism Neuropsychopharmacology 11 133-141

[9] Haddjeri N(2001)Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs Pharmacol Exp Ther 298 651-657

[10] Blier P(2004)Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors Proc Natl Acad Sci USA 101 8186-8191

[1] Argyelan M(2005)Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study J Affect Disord 89 115-123

[2] Szabo Z(2000)Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain Eur Neuropsychopharmacol 10 177-188

[3] Kanyo B(1994)Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs Br J Pharmacol 113 485-495

[4] Tanacs A(1988)Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain Naunyn Schmiedebergs Arch Pharmacol 337 246-254

[5] Kovacs Z(1989)Frequency-dependence of serotonin autoreceptor but not alpha 2-adrenoceptor inhibition of [3H]-serotonin release in rat hypothalamic slices Naunyn Schmiedebergs Arch Pharmacol 339 60-64

[6] Janka Z(1986)In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals J Neurosci 6 2796-2801

[7] Pavics L(1991)Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat Neuropsychopharmacology 5 219-229

[8] Besson A(1994)Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism Neuropsychopharmacology 11 133-141

[9] Haddjeri N(2001)Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs Pharmacol Exp Ther 298 651-657

[10] Blier P(2004)Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors Proc Natl Acad Sci USA 101 8186-8191